Jw Pharmac (001060) — Cash Flow Quality Index
Jw Pharmac (001060) has a Cash Flow Quality Index of 1.80x as of December 2025. Operating cash flow of ₩27.55 Billion exceeds net income of ₩15.32 Billion, indicating high earnings quality where cash backs reported profits. Explore 001060 cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jw Pharmac Cash Flow Quality Index (2001–2025)
Historical Cash Flow Quality Index for Jw Pharmac across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Jw Pharmac total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Jw Pharmac (2001–2025)
Year-by-year earnings quality comparison for Jw Pharmac. For live market cap and the full company financial profile, see Jw Pharmac market cap and net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.57x | ₩96.40 Billion | ₩61.51 Billion | ▲ +28.4% |
| 2024 | 1.22x | ₩79.39 Billion | ₩65.04 Billion | ▼ -51.2% |
| 2023 | 2.50x | ₩87.16 Billion | ₩34.84 Billion | ▲ +47.8% |
| 2022 | 1.69x | ₩56.76 Billion | ₩33.55 Billion | ▼ -73.8% |
| 2018 | 6.47x | ₩52.11 Billion | ₩8.06 Billion | ▲ +403.9% |
| 2015 | -2.13x | ₩-4.17 Billion | ₩1.96 Billion | ▼ -118.0% |
| 2014 | 11.80x | ₩7.28 Billion | ₩617.05 Million | ▲ +41.4% |
| 2013 | 8.34x | ₩18.72 Billion | ₩2.24 Billion | ▲ +1814.8% |
| 2006 | 0.44x | ₩5.07 Billion | ₩11.65 Billion | ▼ -94.4% |
| 2005 | 7.74x | ₩70.25 Billion | ₩9.08 Billion | ▲ +548.9% |
| 2004 | 1.19x | ₩15.02 Billion | ₩12.59 Billion | ▼ -25.1% |
| 2003 | 1.59x | ₩17.05 Billion | ₩10.71 Billion | ▼ -39.7% |
| 2002 | 2.64x | ₩28.74 Billion | ₩10.89 Billion | ▼ -39.9% |
| 2001 | 4.39x | ₩45.04 Billion | ₩10.26 Billion | — |